The pharmaceutical landscape for diabetes is evolving, and GLP-1 patches represent a potential breakthrough. Unlike shots, this approach offers a less invasive way to deliver GLP-1 medications. These devices slowly release the medication through the epidermis offering a consistent level of the ac